Don’t routinely screen for prostate cancer using a prostate-specific antigen (PSA) test or digital rectal exam.
|Rationale and Comments:||There is convincing evidence that PSA-based screening leads to substantial overdiagnosis of prostate tumors. Many tumors will not harm patients, while the risks of treatment are significant. Physicians should not offer or order PSA screening unless they are prepared to engage in shared decision making that enables an informed choice by patients.|
|References:||• American Academy of Family Physicians. Prostate cancer [Internet]. Leawood (KS): American Academy of Family Physicians; 2012 [cited 2013 Jul 23]. Available from: http://www.aafp.org/patient-care/clinical-recommendations/all/prostate-cancer.html.
• U.S. Preventive Services Task Force. Screening for prostate cancer. Rockville (MD): U.S. Preventive Services Task Force. 2012 May. 16 p.